Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
NCT00311220 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2006-04-05
Summary
Tuberculosis is still the most common infectious disease in Taiwan. The infants in Taiwan have been vaccinated at birth with BCG -Tokyo 171 strain since 1951. The BCG vaccination rate is 97% among first grade students in a recent national survey. Even with such a high BCG vaccination coverage, Taiwan still has a relatively high TB incidence rate. In 2004, there were totally 16,784 newly diagnosed TB cases and the annual incidence was 74.11 per 100,000 population nationally. Nearly 70% of the incidence cases were men and 30.4% were women. The mean age of incidence cases was 57.8 years old (median=63). 8,440(50.29%) patients were elderly than 65 years old. The elderly men did not receive the BCG vaccination and were the most important group to develop newly diagnosed tuberculosis and a special issue for the national TB control program in Taiwan.
The tuberculin skin test (TST) is the only widely available method for detecting whether people have an immunologic reactivity to mycobacterial antigens and identified as latent tuberculosis infection (LTBI). Targeted tuberculin testing for latent TB infection is a very important strategy to identify subjects with high risk to develop tuberculosis including those who have recent infection with Mycobacterium tuberculosis or have clinical conditions that associated with an increased risk for progression of LTBI to active TB but the sensitivity was lower in elderly patients.
Quantiferon-TB gold test (QFT-RD1) is a new diagnostic test for latent tuberculosis and a valuable alternative to skin testing. This whole-blood assay measures the production of IFN- in whole blood upon stimulation by ESAT-6 and CFP-10 and allows distinction of latent M. tuberculosis infection from BCG-induced reactivity. ESAT-6 and CFP-10 are deleted from BCG Region 1 (RD1), not present in most nontuberculous mycobacteria and are highly specific indicators of M. tuberculosis infection. Thus, the aim of this study was to estimate the specificity and sensitivity of a whole blood IFN-γassay employing CFP-10 and ESAT-6, for the detection of M. tuberculosis infection in a clustered high risk elderly population.
Changhwa Veterans Home is a government-expense veterans home with totally 519 residents in 2004.The inhabitants were all elderly people and lived in groups. , They did not receive BCG vaccination and were the high risk group to develop endemic TB infection. The annual TB incidence rate over there was 3,500 per 100,000 population.
Conditions
- Tuberculosis
- Latent Tuberculosis
- Tuberculosis Contact
- Elderly
Interventions
- DRUG
-
tuberculin for skin test
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
ChungHwa Veterans house
collaborator UNKNOWN -
Taiwan Province Tau-Wein Hospital
collaborator UNKNOWN -
Taichung Veterans General Hospital
lead OTHER
Principal Investigators
-
Shen Gwan Han, MD · Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 0 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-01-31
- Completion
- 2006-11-30
Countries
- China
More Related Trials
-
The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis
NCT00982969 ·Status: COMPLETED
-
Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan
NCT02208427 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of the QuantiFERON-TB Test.
NCT02142894 ·Status: COMPLETED
-
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140 ·Status: COMPLETED
-
QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
NCT01223534 ·Status: COMPLETED ·Phase: PHASE4
-
Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis
NCT04433195 ·Status: UNKNOWN ·Phase: NA
-
Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
NCT01398618 ·Status: UNKNOWN ·Phase: PHASE3
-
A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI
NCT01642888 ·Status: COMPLETED ·Phase: PHASE3
-
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
NCT06033807 ·Status: RECRUITING
-
Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa
NCT02119130 ·Status: COMPLETED ·Phase: NA
-
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146 ·Status: RECRUITING ·Phase: PHASE3
-
Sensitivity and Specificity of Xpert MTB/RIF Ultra
NCT06058065 ·Status: NOT_YET_RECRUITING
-
Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers
NCT01376843 ·Status: COMPLETED
-
QuantiFERON Change During Anti-tuberculosis Medication
NCT01038830 ·Status: COMPLETED
-
Latent Tuberculosis Infection in Korean Health Care Workers
NCT03010111 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
NCT01099098 ·Status: COMPLETED
-
Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
NCT00491933 ·Status: UNKNOWN ·Phase: NA
-
QuantiFERON Access Clinical Performance Study Protocol
NCT04243031 ·Status: WITHDRAWN
-
Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term Dialysis
NCT01311999 ·Status: COMPLETED
-
The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
NCT01685905 ·Status: UNKNOWN
-
Development of a Rapid and Accurate Diagnostic Assay for Tuberculosis
NCT03423550 ·Status: UNKNOWN
-
Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment
NCT04655794 ·Status: UNKNOWN
-
Xpert MTB/RIF Ultra Trial
NCT07135622 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients
NCT07210970 ·Status: NOT_YET_RECRUITING
-
Performance Evaluation of TB Breath- and Cough-testing Platforms
NCT03025516 ·Status: UNKNOWN